Post by account_disabled on Mar 5, 2024 9:09:51 GMT 5
The world "dodged a bullet" in 2003 when there was an outbreak of the SARS coronavirus, after it was transmitted from bats to humans in China and then spread to 26 countries. The same thing happened when MERS, another coronavirus, spread to humans in 2012. A year later, Chinese scientists found SARS-like viruses in a bat that could infect human cells. And in 2016, the World Health Organization placed coronaviruses among the eight most recognized viral threats, requiring more further study. So one would think we would have some medicine and vaccine by now. But there is no licensee. That's why we're rushing to test drugs designed for other viruses to see if they can help.
Why were we so unprepared for a Cambodia Telegram Number Data threat we knew about? After 2003, there was an explosion of scientific research, but it was short-lived. "From 2005, it became really difficult to get funding for the SARS coronavirus," says Rolf Hilgenfeld at the University of Lübeck, Germany. This was partly because, when SARS disappeared, there was no market waiting for drugs or vaccines to treat it, says David Heymann at the London School of Hygiene. Only big drug companies have the money and expertise to get drugs or vaccines through human trials, and without a market they can't invest. But Hilgenfeld says the agencies funding the research also lost interest because "prominent virologists believed that the SARS coronavirus was a one-time thing.
Read also: ALARM/ There is a new variant of the coronavirus that is spreading rapidly Infections with COVID-19/ 21 citizens have been affected by the virus in the last 24 hours Compared to other coronaviruses, SARS had an extensive genetic mutation, leading some virologists to think that this is what allowed it to spread suddenly in humans – and that such a mutation would be unlikely to happen again. They were right about the second part. The covid-19 virus does not have this mutation, but it spreads even more in humans than SARS. SARS inspired several global measures. MERS was quickly identified in 2012 because the European Union had started funding laboratories for respiratory viruses.
Why were we so unprepared for a Cambodia Telegram Number Data threat we knew about? After 2003, there was an explosion of scientific research, but it was short-lived. "From 2005, it became really difficult to get funding for the SARS coronavirus," says Rolf Hilgenfeld at the University of Lübeck, Germany. This was partly because, when SARS disappeared, there was no market waiting for drugs or vaccines to treat it, says David Heymann at the London School of Hygiene. Only big drug companies have the money and expertise to get drugs or vaccines through human trials, and without a market they can't invest. But Hilgenfeld says the agencies funding the research also lost interest because "prominent virologists believed that the SARS coronavirus was a one-time thing.
Read also: ALARM/ There is a new variant of the coronavirus that is spreading rapidly Infections with COVID-19/ 21 citizens have been affected by the virus in the last 24 hours Compared to other coronaviruses, SARS had an extensive genetic mutation, leading some virologists to think that this is what allowed it to spread suddenly in humans – and that such a mutation would be unlikely to happen again. They were right about the second part. The covid-19 virus does not have this mutation, but it spreads even more in humans than SARS. SARS inspired several global measures. MERS was quickly identified in 2012 because the European Union had started funding laboratories for respiratory viruses.